This elective module covers topics related to medicines development in older patients.
1. Evaluate the barriers & opportunities for developing medicines in a geriatric population. 2. Differentiate between younger & older adults in developing medicines. 3. Consider the regulatory, legal & ethical requirements for medicines development in the geriatric population. 4. Critically assess the barriers to treatment adherence in older adults. 5. Describe pharmacokinetic & pharmacodynamic changes as people get older. 6. Calculate the adequate starting dose for this population. 7. Assess the long-term benefits of medicines taken by the elderly. 8. Describe the methodological aspects of implementing clinical trials and post-marketing studies in this population. 9. Outline the specific aspects of pharmacovigilance in the elderly. 10. Outline the role of Patient & Volunteer Associations.
- Ageing - Cardiovascular disorders - Haematology and oncology